Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease
Clinical trial NCT04432298 · TERMINATED
Trial details
- NCT number
- NCT04432298
- Sponsor
- Kyntra Bio
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2021-03-22
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.